UV-irradiated 2-methyl-4′-(methylthio)-2-morpholinopropiophenone-containing injection solution produced frameshift mutations in the Ames mutagenicity assay

UV-irradiated 2-methyl-4′-(methylthio)-2-morpholinopropiophenone-containing injection solution produced frameshift mutations in the Ames mutagenicity assay
复制标题

DOI:
10.1007/s11356-018-1539-8
复制
发表时间:
2018-02
影响因子:
5.8
通讯作者:
Mariko Takai;Yoichi Kawasaki;S. Arimoto;Yusuke Tanimoto;Y. Kitamura;T. Sendo
Mariko Takai;Yoichi Kawasaki;S. Arimoto;Yusuke Tanimoto;Y. Kitamura;T. Sendo
中科院分区:
环境科学与生态学3区
文献类型:
--
作者:
Mariko Takai;Yoichi Kawasaki;S. Arimoto;Yusuke Tanimoto;Y. Kitamura;T. Sendo

文献摘要

相似文献

在以前的研究中,我们检测到静脉注射液中的光引发剂1-羟基环己基苯基酮(1-HCHPK),2-苯甲酰基苯甲酸甲酯(MBB)和2-甲基-4 ′-(甲硫基)-2-吗啉基苯丙酮(MTMP)。此外,我们报道,1-HCHPK,MBB,和MTMP表现出对正常人外周血单个核细胞的细胞毒性。先前的体外研究报道,自由基光引发剂将共价结合的嘌呤残基引入DNA中。然而,很少有人知道1-HCHPK,MBB,MTMP的体外致突变性。在本体外研究中,我们使用艾姆斯试验评价了1-HCHPK、MBB和MTMP的致突变性。我们发现未处理的1-HCHPK、MBB和MTMP在鼠伤寒沙门氏菌菌株TA 97、TA 98、TA 100、TA 102或TA 1535中无致突变性,无论是否存在S9活化。然而,紫外线(UV)照射的MTMP在没有S9活化的情况下对鼠伤寒沙门氏菌菌株TA 97表现出致突变性。总之,我们认为暴露于紫外线照射的MTMP,包括静脉注射液,可导致移码突变。
In previous studies, we detected the photoinitiators 1-hydroxycyclohexyl phenyl ketone (1-HCHPK), methyl 2-benzoylbenzoate (MBB), and 2-methyl-4′-(methylthio)-2-morpholinopropiophenone (MTMP) in intravenous injection solutions. In addition, we reported that 1-HCHPK, MBB, and MTMP exhibited cytotoxicity towards normal human peripheral blood mononuclear cells. A previous in vitro study reported that a free-radical photoinitiator introduced covalently bound purine residues into DNA. However, little is known about the in vitro mutagenicity of 1-HCHPK, MBB, and MTMP. In the present in vitro study, we evaluated the mutagenicity of 1-HCHPK, MBB, and MTMP using the Ames test. We found that untreated 1-HCHPK, MBB, and MTMP were not mutagenic inS. typhimuriumstrain TA97, TA98, TA100, TA102, or TA1535, regardless of the presence/absence of S9 activation. However, ultraviolet (UV) light-irradiated MTMP exhibited mutagenicity inS. typhimuriumstrain TA97 in the absence of S9 activation. In conclusion, we suggest that exposure to UV-irradiated MTMP, including in intravenous injection solutions, can result in frameshift mutations.